Search
Butriptyline
go.drugbank.com/drugs/DB09016ApprovedWithdrawnButriptyline is a tricyclic antidepressant which has been used in Europe since 1974. It is the isobutyl side chain homologue of amitriptyline.
Categories: Serotonin 5-HT2 Receptor Antagonists, Serotonin 5-HT2A Receptor AntagonistsAloe ferox leaf
go.drugbank.com/drugs/DB14257ApprovedAloe ferox leaf is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
Eucalyptus globulus leaf
go.drugbank.com/drugs/DB14320ApprovedEucalyptus globulus leaf is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
Heterotheca inuloides flower
go.drugbank.com/drugs/DB14331ApprovedHeterotheca inuloides flower is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
Nelumbo nucifera flower
go.drugbank.com/drugs/DB14333ApprovedNelumbo nucifera flower is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
Arnica montana flower
go.drugbank.com/drugs/DB14343ApprovedArnica montana flower is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
Synonyms: Arnica Flower (Arnica Montana L.), Arnicae Flos (Arnica Montana L.)Equisetum arvense top
go.drugbank.com/drugs/DB14349ApprovedWithdrawnEquisetum arvense top is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
Mixtures: Vegetal Silica 5:1Salix alba bark
go.drugbank.com/drugs/DB14274ApprovedSalix alba bark is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
Cintredekin besudotox
go.drugbank.com/drugs/DB05305InvestigationalCintredekin besudotox is made from a human protein, Interleukin 13 (IL13), linked to a bacterial toxin, _Pseudomonas exotoxin_ (PE). The IL13 portion binds to receptors on the tumor. … Cintredekin besudotox has been developed as a specific tumor-targeting agent, which is administered by positive-pressure convection-enhanced delivery (CED) directly to brain tissue at risk for residual